SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-15-047499
Filing Date
2015-08-10
Accepted
2015-08-10 06:35:28
Documents
7
Period of Report
2015-08-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v417666_8k.htm 8-K 32790
2 EXHIBIT 10.1 v417666_ex10-1.htm EX-10.1 325234
3 EXHIBIT 10.2 v417666_ex10-2.htm EX-10.2 132771
4 EXHIBIT 10.3 v417666_ex10-3.htm EX-10.3 17240
5 EXHIBIT 99.1 v417666_ex99-1.htm EX-99.1 16464
6 GRAPHIC t99-1logo.jpg GRAPHIC 9827
7 GRAPHIC t99-1logo1.jpg GRAPHIC 9840
  Complete submission text file 0001144204-15-047499.txt   553342
Mailing Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850
Business Address 617 DETROIT STREET, SUITE 100 ANN ARBOR MI 48104 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 151039148
SIC: 2834 Pharmaceutical Preparations